B*******y
发帖数: 766 | 1 from C&EN
GlaxoSmithKline's year-end shopping spree continued with a licensing deal
worth up to $2.1 billion for Genmab's late-stage cancer drug. The pact
includes a $102 million up-front fee and a $357 million stake in the Danish
firm.
GSK gains the rights to HuMax-CD20, a fully human monoclonal antibody
currently in Phase III trials for treatment of both non-Hodgkin's lymphoma
and a type of leukemia. It is in Phase II studies to treat patients with
rheumatoid arthritis.
The lofty price tag hig |
B*******y
发帖数: 766 | 2 不知道这个genmab是干什么的
Danish
companies
【在 B*******y 的大作中提到】
: from C&EN
: GlaxoSmithKline's year-end shopping spree continued with a licensing deal
: worth up to $2.1 billion for Genmab's late-stage cancer drug. The pact
: includes a $102 million up-front fee and a $357 million stake in the Danish
: firm.
: GSK gains the rights to HuMax-CD20, a fully human monoclonal antibody
: currently in Phase III trials for treatment of both non-Hodgkin's lymphoma
: and a type of leukemia. It is in Phase II studies to treat patients with
: rheumatoid arthritis.
: The lofty price tag hig
|
r***o
发帖数: 162 | 3 This is a no brainer choice.
The concept has been approved. If the safety profile is good ( should be
good based on the GSK's decision), it will get approved for cancer
indication, then additional anti-inflamation indications.
Danish
companies
【在 B*******y 的大作中提到】
: from C&EN
: GlaxoSmithKline's year-end shopping spree continued with a licensing deal
: worth up to $2.1 billion for Genmab's late-stage cancer drug. The pact
: includes a $102 million up-front fee and a $357 million stake in the Danish
: firm.
: GSK gains the rights to HuMax-CD20, a fully human monoclonal antibody
: currently in Phase III trials for treatment of both non-Hodgkin's lymphoma
: and a type of leukemia. It is in Phase II studies to treat patients with
: rheumatoid arthritis.
: The lofty price tag hig
|
i*********n
发帖数: 38 | 4 Compared to other big pharmas, GSK's own oncology pipeline is rather weak.
I guess they have to buy late-stage products to stay in the game. I'm not a
big fan of cancer immunotherapy, though. Let's see how this one works out. |
U******m
发帖数: 423 | 5
Genmab: Generating monoclonal Antibody?
【在 B*******y 的大作中提到】
: 不知道这个genmab是干什么的
:
: Danish
: companies
|
